Romano Subiotto QC

Partner

ブリュッセル
T: +32 2 287 2000
 F: +32 2 231 1661
ロンドン
T: +44 20 7614 2296
 F: +44 20 7600 1698
 rsubiotto@cgsh.com

Romano F. Subiotto QC is a partner based in the Brussels and London offices.

Mr. Subiotto advises companies on a wide range of issues under European and national antitrust law, and represents companies in arbitrations and before the European Commission, national antitrust authorities, the European Courts in Luxembourg and the High Court in London. Mr. Subiotto has spoken widely on EU law issues and published numerous articles. He is also distinguished as a leading Competition/Antitrust lawyer by Chambers and Partners Global - The World’s Leading Lawyers. Mr. Subiotto is a member of the Court of Arbitration for Sport as well as a member of the Advisory Council of Harvard Law School's Institute for Global Law and Policy. In 2013, Mr. Subiotto was appointed as an Anti-Corruption Hearing Officer pursuant to the Uniform Tennis Anti-Corruption Program.

Mr. Subiotto also regularly advises companies on a wide range of industrial sectors, including diamonds (Alrosa), payment cards (American Express), pharmaceutical products (Amgen, Boehringer Ingelheim, Debiopharm, Lundbeck, Merck & Co. Inc., Millenium Pharmaceuticals, PhRma, sanofi-aventis), diagnostics (association of diagnostics manufacturers, Agilent Technologies), electronic measurement instruments (Agilent Technologies), air transport (British Airways, Lauda Air, TAT European Airlines), luxury products (Richemont, LVMH), telecommunications (Telefonica O2), cosmetics (Estée Lauder, Sephora), sports (FIFA Marketing, the IOC, the Grand Slam Committee), alcoholic beverages (LVMH), hospital beds (Hillenbrand), computer hardware (Logitech), animal health (Merial Intervet), plant protection (Bayer CropScience), radiopharmaceuticals (MSD Nordion), glass fibers (Owens Corning), rail transport (Russian Railways) security services (Securitas, Stanley Black & Decker), karting (Vega), offshore drilling (SeaDrill).

Illustrative experience in litigation before the European Courts over the last fifteen years include:

  • Case T-45/12 United Kingdom of Great Britain and Northern Ireland v. European Central Bank (lead counsel for the ECB) Re: Challenge to the ECB’s standards for the use of central counterparties in euro system foreign reserve management operations.
  • Case T-496/11 United Kingdom of Great Britain and Northern Ireland v. The European Central Bank (lead counsel for the ECB) Re: Challenge to the ECB's framework policy concerning the location of central counterparty clearing systems handling euro-denominated transactions.
  • Case C-207/10 Paranova Danmark A/S and Paranova Pack A/S v. Merck Shape & Dohme B.V. and Merck Shape & Dohme (lead counsel for Merck) Re: Indication of repackager on new packaging of imported machines.
  • Case C-400/09 Orifarm A/S, Orifarm Supply A/S, Handelsselskabet A/S and Ompakningsselskabet A/S v. Merck & Co. Inc., Merck Sharp & Dohme B.V. and Merck Sharp & Dohme (lead counsel for Merck) Re: Indication of repackager on new packaging of imported medicines.
  • Case T-540/08 Esso Société Anonyme Française and Others v. Commission of the European Communities Re: Appeal against a Commission decision fining the appellants for cartel activities.
  • Case C-441/07 P Commission/ALROSA Company Ltd. (lead counsel for ALROSA). Re: Commission appeal against Court of First Instance judgment annulling the Commission decision.
  • Case T-170/06 ALROSA Company Ltd v. Commission (lead counsel for ALROSA). Re: Appeal against EC Commission decision prohibiting sale of diamonds by ALROSA to De Beers.
  • Case C-431/05 Merck Genéricos Produtos Farmacéuticos v. Merck & Co. Inc. (counsel for Merck & Co. Inc.). Re: Direct effect of TRIPS Agreement in national law (reference from Portugal’s Supreme Court).
  • Case C-348/04 Boehringer Ingelheim e.a. (lead counsel for Boehringer Ingelheim). Re: Extent of rights of parallel importers to tamper with original pharmaceutical packaging (reference from UK Court of Appeal).
  • Case C-95/04P British Airways v. Commission (lead counsel for British Airways). Re: Regulation of rebates granted by a dominant company under Article 82 EC (appeal against judgment of Court of First Instance).
  • Case C-252/03 Ministre de l’Economie v. Millennium Pharmaceutical Inc. (lead counsel for Millennium, language of case: French). Re: Effect of the 1924 Switzerland-Liechtenstein customs union on interpretation of the EC Regulation on Supplementary Protection Certificates (reference from the Cour Administrative of the Grand Duchy of Luxembourg).
  • Case C-245/03 Merck, Sharp & Dohme B.V. v. Etat belge (lead counsel for Merck, language of case: French). Re: Interpretation of EC Directive on the transparency of national price-fixing and reimbursement measures for pharmaceuticals.
  • Case C-143/00 Boehringer Ingelheim and others v. Swingward Ltd. and another (lead counsel for Boehringer Ingelheim). Re: Extent of rights of parallel importers to tamper with original pharmaceutical packaging (reference from UK High Court).
  • Case C-443/99 Merck, Sharp & Dohme v. Paranova Pharmazeutika Handels (lead counsel for Merck, language of case: German). Re: Extent of rights of parallel importers to tamper with original pharmaceutical packaging (reference from Austrian court).
  • Case T-49/97 TAT European Airlines SA v. Commission (lead counsel for the applicants). Re: Appeal against Commission decision authorizing the payment of the third tranche of the FRF 20 billion state aid to Air France.
  • Case T-60/96 Merck & Co. Inc., NV Organon, and Glaxo Wellcome plc v Commission (lead counsel for appellants). Re: Commission refusal to adopt emergency measures blocking exports of pharmaceutical products outside Spain.
  • Case T-236/95 TAT European Airlines SA v. Commission (lead counsel for the applicants). Re: Appeal against Commission decision authorizing the payment of the second tranche of the FRF 20 billion state aid to Air France.
  • Joined Cases C-267/95 and C-268/95 Merck & Co. Inc. and Others v. Primecrown Ltd and Others and Beecham Group plc v. Europharm of Worthing Ltd (lead counsel for Merck). Re: Attempted reversal of EC law on patent exhaustion.
  • Joined Cases T-371/94 British Airways plc, Scandinavian Airlines System Denmark-Norway-Sweden, Koninklijke Luchtvaart Maatschappij NV, Air UK Ltd, Euralair International, TAT European Airlines (applicants in Case T-371/94) and British Midland (applicant in Case T-394/94) v. Commission (sole counsel for the applicants). Re: Appeal against Commission decision authorizing FRF 20 billion aid to Air France. The decision was annulled.
  • Case T-260/94 Air Inter SA v. Commission of the European Communities (lead counsel for the intervener, TAT European Airlines).
  • Case T-2/93 Société anonyme à participation ouvrière Compagnie nationale Air France v. Commission of the European Communities (lead counsel for the intervener TAT).
  • Case C-222/91 Ministero delle Finanze and Ministero della Sanità v. Philip Morris Belgium SA, and others (member of team lead counsel for Philip Morris).
  • Case T-35/91 Eurosport v. Commission, withdrawn, (member of team intervening on behalf of Sky Television plc).  

Illustrative experience as an arbitrator in cases brought to the Court of Arbitration for Sport includes:
  • CAS 2007/A/1395 WADA v. NSAM & Cheah & Ng & Masitah.
  • CAS 2008/A/1504 SC Politehnica 1921 Stiinta Timisoara Invest SA v. Clubul Sportiv FC Srbianka Giuchici.
  • CAS 2008/A/1479 WADA v. CONI, FPI & Elga Comastri.
  • CAS 2008/A/1478 Gianluca Coletta v. CONI (chairman).
  • CAS 2008/A/1571 Nusaybindemir SC v/ TFA & Sinak SC (chairman).
  • CAS 2008/A/1646 Luca D’Andrea v. CONI (chairman).
  • CAS 2008/A/1618 Marco Cedroni v. CONI (chairman).
  • CAS 2008/A/1707 MKE Ankaragücu Sports Club v. Huzeyfe Dogan (sole arbitrator) (withdrawn).
  • CAS 2008/A/1712 Marta Bastianelli v. CONI, consolidated with CAS 2008/A/1742 UCI v. Marta Bastianelli & FCI (chairman).
  • CAS 2008/A/1744 UCI v. Schachl & ÖRV (chairman).
  • CAS 2009/A/1807 UCI v. Gallucci & FCI & CONI (chairman).
  • CAS 2009/A/1859 Besiktas Jimnastik Kulübü v. FIBA Europe (chairman) (withdrawn).
  • CAS 2009/A/1879 Alejandro Valverde Belmonte v. CONI (chairman).
  • CAS 2009/O/2007 Lorito Venture Capital. 
  • CAS 2009/A/2024 Giovanni Lucchetti v. CONI (chairman).
  • CAS 2010/A/2045 Olympique Lyonnais v. UEFA & Fortuna Hjørring (chairman).
  • CAS 2010/A/2063 UCI v. José Antonio Redondo Ramos & RFEC (chairman).
  • CAS 2010/A/2108 Jamaican Football Federation v. FIFA & Vellbor Milutinovic (chairman). 
  • CAS 2010/A/2120 Desportivo Brasil v. FIFA & Schalke 04 (chairman) (withdrawn).
  • CAS 2010/A/2070 Antidoping Switzerland v. Jan Ullrich (chairman).
  • CAS 2010/A/2083 UCI v. Jan Ullrich & Swiss Olympic (chairman).
  • CAS 2010/A/2178 Pietro Caucchioli v. CONI & UCI (chairman).
  • CAS 2010/A/2201 M. Andrea Mangiante v. CONI & UCI.
  • CAS 2010/O/2163 Ilija Ivic v. FK Crvena Zvezda (sole arbitrator)
  • CAS 2010/A/2229 WADA v. FIVB & Gregory Berrios (chairman).
  • CAS 2010/A/2234 Basquet Menorca SAD v. Vladimer Boisa (chairman).
  • CAS 2010/A/2252 Oleksandr Zavarov v. FC Arsenal Kiev (chairman).
  • CAS 2010/A/2162 Doping Control Centre, Universiti Sains Malaysia v. WADA (chairman).
  • CAS 2010/A/2308 Franco Pellizotti v. CONI & UCI, and CAS 2011/A/2335 UCI v. Franco Pellizotti, FCI, CONI (chairman).
  • CAS 2011/A/2362 Mohammad Asif v. International Cricket Council.
  • CAS 2011/A/2364 Salman Butt v. International Cricket Council.
  • CAS 2011/A/2445 José Luis Sáez c. COE (chairman).
  • CAS 2011/A/2456 Luciano Galletti v. Olympiakos FC & HFF (chairman).
  • CAS 2011/A/2463 Aris FC v. Javier Edgardo Campora & HFF (chairman).
  • CAS 2011/A/2490 Daniel Köllerer v. Association of Tennis Professionals, Women’s Tennis Association, International Tennis Federation & Grand Slam Committee (chairman).
  • CAS 2011/A/2501 UCI c/Julian David Muñoz Giraldo & Federacion Colombiana de Ciclismo (FCC) (chairman).
  • CAS 2011/A/2543 Gymnova v. FIG (chairman).
  • CAS 2011/A/2566 Andrus Veerpalu v. International Ski Federation (chairman).
  • CAS 2011/A/2586 William Lanes de Lima v/ FIFA (chairman).
  • CAS 2011/A/2625 Mohamed Bin Hammam v. FIFA.
  • CAS 2011/A/2615 Thibaut Fauconnet v. International Skating Union / CAS 2011/A/2618 International Skating Union v. Thibaut Fauconnet (chairman).
  • CAS 2011/A/2665 Persipura Jayapura v. the Football Association of Indonesia (PSSI), the Asian Football Confederation (AFC) & Adelaide United FC (chairman).
  • CAS 2011/A/2678 IAAF v. RFEA & Francisco Fernández Peláez (sole arbitrator).
  • CAS 2012/O/2722 Francisco Pavón v. AC Arles-Avignon (chairman).
  • CAS 2012/A/2731 Brazilian Olympic Committee & Brazilian taekwondo Confederation & Márcio Wencesiau Ferreira v. World Taekwondo Federación & Comité Olímpico Mexicano & Federación Mexicana de Taekwondo & Damien Alejandro Villa Valadez (chairman).
  • CAS 2012/O/2734 Álvaro Mejía v. AC Arles-Avignon (chairman).
  • CAS 2012/A/2773 The International Association of Athletics Federations (IAAF) v. The Greek Athletics Federation (SEGAS) & Ms Irini Kokkinariou (sole arbitrator).
  • CAS 2012/A/2775 Al-Gharafa S.C. v. Hakan Yakin & FC Luzern (chairman).
  • CAS 2012/A/2851 FC Metallurg v. Tkachenko Sergey Viktorovich (chairman).
  • CAS 2012/A/2879 Associação Atlética Ponte Preta v. Ittihad Club (chairman) (withdrawn).
  • CAS 2012/A/2907 Abderrahim Goumri c. Fédération Royale Marocaine d’Athlétisme (FRMA) (withdrawn).
  • CAS 2012/O/2923 Bologna FC 1909 S.p.A v. Real Club Deportivo Espanyol de Barcelona (withdrawn).
  • CAS 2012/A/2959 World Anti-doping Agency (WADA) v. Ali Nilforushan & Fédération Equestre Internationale (FEI) (chairman).
  • CAS 2012/A/2972 Matti Helminen v. RLVB (chairman).
  • CAS 2012/A/2999 Dario Orlando Donadio c/Raúl Bravo Sanfélix (chairman).
  • CAS 2012/A/3024 Slovak Tennis Federation, Slovak Cycling Federation, Slovak Handball Federation, Slovak Football Association v. Slovak Olympic Committee (chairman).
  • CAS 2012/A/3046 Amine Laalou v. FRMA
  • CAS 2013/A/3071 Ana Beatriz di Rienzo Bulcão v. Fédération Internationale d´Escrime

Illustrative experience in arbitration includes the representation of Aventis and its subsidiary Aventis CropScience in an ICC arbitration commenced by The Scotts Company regarding the enforceability of a non-competition clause entered into at the time of the sale by Rhone-Poulenc Agrochimie, a subsidiary of Aventis CropScience, of its home and garden business to The Scotts Company.

Illustrative experience in national litigation includes:
  • Joined cases Adidas Salomon AG v. Lawn Tennis Association and others and Adidas Salomon AG v. International Tennis Federation and others. Re: Representation of The Lawn Tennis Association, and The All England Lawn Tennis And Croquet Club and Tennis Australia in two joined English High Court actions relating to alleged breaches of EU and UK competition law brought by Adidas Salomon AG against the operators of the "Grand Slam" tennis tournaments and the International Tennis Federation. 
  • The Queen (on the application of James Alistair Preston) v. Wandsworth Borough Council and the Secretary of State for Justice (2010-2011). Re: Counsel to Mr. James Preston in a judicial review action concerning a law that disenfranchises British citizens living outside the United Kingdom for more than 15 years.
  • Toshiba Carrier UK Ltd. and others v. KME Yorkshire Ltd. and others (2011).  Re: Counsel to the KME group of companies in damages action following on from an EU Commission decision finding that the KME group of companies had participated in a cartel. 

Mr. Subiotto joined the firm in 1988 and became a partner in 1997. He received his Diploma de Estudios Hispánicos from the University of Málaga, Spain in 1980; his LL.B., First Class Honours, from the University of London, King's College, in 1984 (Harold Potter Prize in Property Law, Laws Exhibition, Second Maxwell Law Prize); his Maîtrise en Droit, Mention Bien, from the University of Paris I, Panthéon-Sorbonne, in the same year; and his LL.M. from Harvard Law School in 1986, where he was a John F. Kennedy Memorial Scholar.

Mr. Subiotto qualified as a Solicitor of the Senior Courts of England and Wales in 1988, and was appointed Queen's Counsel in 2009. Mr. Subiotto is also a member of the Bar in Brussels. He is fluent in English, French, Italian, Spanish and German.

Publications

1.“Antitrust and Antidoping Do Not Mix", Jusletter - Edition spéciale: Droit du sport, July 16, 2012.

2. “The Application of Article 102 TFEU by the European Commission and the European Courts”, Journal of European Competition Law & Practice, February 2012, Vol. 3, No. 2.

3. “Antitrust Developments in Europe 2010”, LexisNexis, October 2011.

4. “The Reform of European Distribution Law”, World Competition 34, no. 1 (2011).

5. “Recent EU Case Law Developments: Article 102 TFEU”, Journal of European Competition Law & Practice, December 2010.

6. “IP and Antitrust in the Pharma Sector – Where Does the EU Commission Stand at Present”, Ninth Annual Harvard Seminar, Harvard Law School, Cambridge, October 21, 2010.

7. "The Adoption and Enforcement of Anti-Doping Rules Should Not Be Subject To European Competition Law", European Competition Law Review, June 2010, Volume 31, Issue 8.

8. “Antitrust Developments in Europe 2009”, LexisNexis, June 2010.

9. “Deliberate Concealment in Cartel Claims”, The CPI Antitrust Journal, May 2010.

10. “EU Antitrust: A 50-Year Retrospective”, CGSH Global Antitrust seminar, Brussels, April 22, 2010.

11. “The muzzled British diaspora in the EU”, European Voice, April 22, 2010.

12. “UK follow-on damages claims after Enron”, Global Competition Review, April 2010.

13. “Key Features of 2009 Cartel Cases”, Journal of European Competition Law & Practice, April 2010, Vol. 1, No. 2.

14. “L’arbitrage des litiges sportifs”, Barreau de Paris, Paris, March 25, 2010.

15. “Droit Communautaire de la Concurrence”, two-day seminar at the University of Montpellier, December 10-11, 2009.

16. “Developments, Q&A and Panel Discussion: Pharmaceutical Sector Inquiry”, Advanced EC Competition Law 2009, Brussels, November 18-19, 2009.

17. “The Interaction Between IP and European Competition Law: The Example of the Recent Pharmaceutical Sector Inquiry”, Eighth Annual Harvard Seminar, Harvard Law School, Cambridge, November 5, 2009.

18. “Focus on the Pharmaceutical Patenting – EU Commission Sectoral Inquiry in Pharmaceutical Industry”, Competition & IPR, University of Helsinki, October 6, 2009. 

19. “Arbitration and Mediation in Competition Law Cases”, Antitrust Litigation 2009, London, October 2, 2009.

20. “How a Lack of Analytical Rigour has Resulted in an Overbroad Application of EC Competition Law in the Sports Sector”, Sweet & Maxwell International Sports Law Review, Issue 2, 2009.

21. “Antitrust Developments in Europe 2008”, LexisNexis, June 2009.

22. “Advanced EC Competition Law London 2009, Pharma Sector Findings, Panel Discussion and Q&A: Sector Inquiries”, IBC’s 18th Annual Event, London, April 22, 2009.

23. “Unjustified Expansion of EC Competition Law into the Sports Sector”, British Sky Broadcasting Ltd., London, April 21, 2009.

24. “The Interface between Competition Law and Intellectual Property Rights: Focus on the Pharmaceutical Industry”, Lund University, Sweden, January 23, 2009. 

25. “Droit Communautaire de la Concurrence”, two-day seminar at the University of Montpellier, December 10-11, 2008.

26. “Competition Problems in the Pharma Sector”, Summit at Como, Lake Como, October 24-26, 2008.

27. “The Increasing Use of Settlements in Europe”, Seventh Annual Harvard Seminar, Harvard Law School, Cambridge, October 1, 2008.

28. “Antitrust Issues in Europe: Competition Policy, Enforcement & Interacting with Regulators in the EU”, 2008 Chief Litigation Counsel Association Spring Meeting, New York, May 8, 2008.

29. “An Overview of the EU”, Logitech WW Legal Off-Site, Rome, April 2, 2008.

30. “BA vs. Virgin: A New Economic Approach?”, ASAS-Studienvereinigung Kartellrecht, Geneva, January 31, 2008.

31. “Droit Communautaire de la Concurrence”, two-day seminar at the University of Montpellier, November 29 -30, 2007.

32. “The Developing Legal Framework Governing Commitments”, IBC’s 16th Annual Conference, Brussels, November 23, 2007.

33. “Developments Concerning Payment Cards”, Summit at Como, Lake Como, October 26-28, 2007.

34. “Cartel Enforecement: A View From Brussels”, Sixth Annual Harvard Seminar, Harvard Law School, Cambridge, October 11, 2007.

35. “Private Antitrust Enforcement: A Practical Guide to Managing Competition Litigation in Europe”, CGSH seminar, London, September 14, 2007.

36. “Restricting Parallel Trade – Legal Issues”, EU Pharma Law and Regulation, London, June 21, 2007.

37. “The Conundrum Facing the Generic Industry in its Attempt to Enter the EU and US Market”, 6th Annual Pharmaceutical Patent Lifecycles, London, January 23, 2007.

38. “Where Does the Industry Stand on the Parallel Import Front?”, 6th Annual Pharmaceutical Patent Lifecycles, London, January 22, 2007.

39. “Droit Communautaire de la Concurrence”, two-day seminar at the University of Montpellier, December 12 -13, 2006.

40. “The EU Commission’s Attempts at Defining Abusive Behavior”, Fifth Annual Harvard Seminar, Harvard Law School, September 27, 2006.

41. “Parallel Imports – Where Do We Stand”, EU Pharma Law & Regulations, London, September 19, 2006.

42. “Third Party Access-Intellectual Property Rights: The Merck/Italia Dobfar case”, College of Europe, Bruges, June 22, 2006.

43. “Antitrust Developments in Europe 2005”, Kluwer Law International, The Hague, June 2006.

44. “Free Movement and Parallel Trade”, The EU Pharmaceutical Law Forum, Brussels, May 15-16, 2006.

45. “Obligations de service public et refus de vente des laboratoires pharmaceutiques”, Revue Lamy de la Concurrence, N° 5, novembre/décembre 2005.

46. “Droit Communautaire de la Concurrence”, two-day seminar at the University of Montpellier, December 8-9, 2005.

47. “Media Content in the EU”, GCLC-BT Conference, London, December 5, 2005.

48. “Market Definition in Competition Law - What it is About and How to Approach it in Practice”, Henkel Workshop, Germany, October 21, 2005.

49. “The Current Rethinking by European Antitrust Authorities of What Constitutes Abuse of Market Power”, Harvard Law School, Cambridge, September 30, 2005.

50. “Antitrust Developments in Europe 2004”, Kluwer Law International, The Hague, June 2005.

51. “European Antitrust Compliance”, Owens Corning Seminar, Brussels, May 24, 2005.

52. “The Regulation of Discriminatory Conduct Under the EC Treaty”, UTC Seminar, Berlin, May 9, 2005.

53. “EC Treaty Rules concerning the Overstickering or Reboxing of a Pharmaceutical’s Original Packaging”, Pharmaceutical Law Europe 2005, London, January 27, 2005.

54. “Droit européen de la concurrence et de la propriété intellectuelle”, Pierre Fabre Seminar, Sorèze, December 9-10, 2004.

55. “The Application of EC Competition Law to Distribution Arrangements: The Case of the Pharmaceutical Sector”, Harvard Law School, Cambridge, October 12, 2004.

56. “Licenses for New Media Rights under EC Law on Competition”, Entertainment and Sports Lawyer, Vol. 22, No. 1, Spring 2004.

57. “Antitrust Developments in Europe 2003”, Kluwer Law International, The Hague, June 2004.

58. “The Origins and Functioning of the European Community”, Estée Lauder Seminar, New York, May 18, 2004.

59. “Free Movement and Parallel Trade in the Pharmaceutical Sector”, The EU Pharmaceutical Law Forum, Brussels, May 13-14, 2004.

60. “The Legal Framework Applicable to Practices of Pharmaceutical Companies with Respect to Parallel Trade”, European Pharmaceutical Law 2004”, Brussels, January 22, 2004.

61. “Analysis of the Principles Applicable to the Review of Exclusive Broadcasting Licences Under EC Competition Law”, World Competition, 26(4), p. 589-608, 2003.

62. “Defining the Scope of the Duty of Dominant Firms to Deal with Existing Customers under Article 82 EC”, European Competition Law Review, Volume 24, Issue 12, December 2003.

63. “An Overview of Recent Abusive Practices in the EC ”, Harvard Law School, Cambridge, September 30, 2003.

64. “Antitrust Developments in Europe 2002”, Kluwer Law International, The Hague, June 2003.

65. “Trends & Priorities in U.S. Antitrust Enforcement: Are the Divergences with the EU Growing or Narrowing?”, CGSH Seminar, Brussels, June 12, 2003.

66. “Issues Arising Under Regulation 1/2003”, ExxonMobil seminar, Brussels, June 11, 2003.

67. “Current Law, Recent Trends and New Challenges”, The EU Pharmaceutical Law Forum, Brussels, May 12-13, 2003.

68. “Vertical Issues in Broadcasting Contracts under EC Competition Law”, Broadcasting Competition Law Conference, Brussels, January 14, 2003.

69. “Droit Communautaire de la Concurrence”, two-day seminar at the University of Montpellier, December 12-13, 2002.

70. “Free Movement of Goods and the Protection of Trademarks”, The Journal of World Intellectual Property, Vol. 5, No. 6, November 2002.

71. “The Extent of a Third-Party’s Right to Modify Original Packaging under EU Law”, IPL Newsletter, Vol. 21, Number 1, Fall 2002.

72. “The Interface of Intellectual Property Rights and Antitrust Laws under US/EU Law”, presentation for Merck & Co., Inc.’s OGC Seminar, New Jersey, October 24, 2002.

73. “Current Developments in EC & U.S. Antitrust Law”, Harvard Law School, Cambridge, October 10, 2002.

74. “The Reform of The European Competition Policy Concerning Vertical Restraints”, Antitrust Law Journal, Vol. 69, Issue 1, p. 147.

75. “Antitrust Developments in Europe 2001”, Kluwer Law International, The Hague, June 2002.

76. “Free Movement and Packaging”, The EU Pharmaceutical Forum, Brussels, May 23, 2002.

77. “Droit Communautaire de la Concurrence”, two-day seminar at the University of Montpellier, December 12-15, 2001.

78. “Goals and Problems of State Competition Policy in Regions of the Russian Federation”, International Conference for the 10th Anniversary of the Creation of the St. Petersburg Antimonopoly Committee, St. Petersburg, October 9-10, 2001.

79. “Free Movement of Goods and Trademarks”, Parallel Trade in Pharmaceuticals conference, Geneva, September 13, 2001.

80. “Free Movement, Repackaging, Re-Labelling Update”, The EU Pharmaceutical Law Forum, Rome, May 15-16, 2001.

81. "Sports Marketing and Management and the Law", London, November 1, 2000.

82. "Current Reforms in EC Competition Law", ISL Worldwide Legal Retreat, Lucerne, October 20, 2000.

83. "Preliminary Analysis of the Commission's Reform Concerning Vertical Restraints", Journal of World Competition 23(2); 5-26, 2000, p. 1.

84. "Overview of the EU Legal System", presentation for Philip Morris Seminar, Evian, April 13, 2000.

85. "Transactions Subject to EC Review & Notification of Mergers and Acquisitions in the United Kingdom", CGS&H Seminar on Antitrust Issues in Mergers and Acquisitions in the United States and Europe, New York, June 24, 1999.

86. "Pricing Issues under Article 82 (formerly Art. 86)", presentation for DuPont Seminar on European Antitrust Issues, Brussels, June 16, 1999.

87. "State Aid & Judicial Review in the Air Transport Sector", European Air Transport Services and Airports conference, Brussels, June 11, 1999.

88. "Problems Arising from State Aids in the Banking Sector", Competition Workshop on State Aid Control in the European Union -- Selected Problems, Florence, June 4-6, 1999.

89. "Current Issues Concerning Open Skies and Transatlantic Airline Alliances", Air Transport Association of America, Brussels, September 10, 1998.

90. "European Community Law", presentation for Merck & Co., Inc., New Jersey, October 23, 1997.

91. "Judicial Treatment of Competition Law in the European Union", Antimonopoly Law and its Enforcement in the Russian Federation, St. Petersburg, May 23, 1997.

92. "New EC Technology Transfer Regulation", Association of Corporate Patent Counsel, Hot Springs, Virginia, June 17-19, 1996.

93. "Factors Involved in Opening Second-Stage Proceedings", European Study Conferences' Fifth EU Mergers and Joint Ventures Symposium, Brussels, March 21-22, 1996.

94. "New EC Technology Transfer Regulation", PILLS Antitrust and Licensing, New York, March 15, 1996.

95. "Introduction to EC Competition Law", Slovenian Regional Workshop, Slovenia, November 3-7, 1995.

96. "Recent Developments in EC Air Transport Law and Policy, Panel Discussion on State Aids", European Air Law Association, London, November 3, 1995.

97. "Legal Principles Governing State Aid and the Commission's Review of State Aid", European Air Law Association: Seventh Annual Conference, London, November 3, 1995.

98. "Technology Licensing: The EC and US Rules Compared", The Law Society's Solicitors' European Group Annual Conference, Brussels, June 16-17, 1995.

99. "The Confines of the Special Responsibility of Dominant Undertakings not to Impair Genuine Undistorted Competition", World Competition, Law and Economics Review, May 1995, p. 5.

100. "Developments in Article 86", IBC's EC Competition Law Conference, Brussels, November 8-9, 1994.

101. "Competition in the European Telecommunications Sector: The Telecommunications Challenge for the 90s", The Irish Centre for Commercial Law Studies, Competition in the Public Sector, Dublin, November 30, 1993.

102. "The Right to Deal with Whom One Pleases under EEC Competition Law: A Small Contribution to a Necessary Debate", [1992] 6 ECLR 234.

103. "Le Contrôle des Opérations de Concentration entre Entreprises au Niveau Européen -- Une Première Analyse Pratique", Revue Trimestrielle de Droit Européen, 28(1), p. 51.

104. "El Control Europeo de las Operaciones de Concentracion de Empresas -- Un Primer Analisis Practico", Gaceta juridica de la C.E., 1992, D-16, p. 9.

105. "Il Controllo delle Concentrazioni a livello CEE -- Una prima Analisi Pratica delle Decisioni della Commissione", Giurisprudenza Commerciale, 1992, No. 2, p. 233.

106. "EC Electricity and Gas: Proposed Legislation", 1(2) Utility Law Report, (1992), 8.

107. "Abuse of a Dominant Position", The Irish Centre for Commercial Law Studies, Practising Competition Law, Dublin, April 16, 1992.

108. "The Concept of Abuse: Identification and Classification of Types of Abusive Conduct -- The Relationship between the Existence of Dominance and the Concept of Abuse in Light of Decided Cases", 11th Annual International Antitrust Law Conference, Cambridge, September 10, 1992.

109. "The EEC Merger Control Regulation: The Commission's Evolving Case Law", 28 CMLRev. (1991), p. 877.

110. "Ein Jahr EG-Fusionskontrolle -- eine Zwischenbilanz aus der Sicht des Praktikers", Wirtschaft und Wettbewerb, 1991, p. 872.

111. "Notifying EEC Mergers and Alliances: The Evolving Case Law under the EEC Merger Control Regulation", PLC, Vol. II, No. 6 (1991), p. 3.

112. "Public Procurement", 1(1) Utility Law Report, (1991), 14.

113. "European Control of Monopolistic Utilities: France v. Commission", Vol. 9, No. 3, Journal of Energy and Natural Resources Law, 212 (co-author: Antoine Winckler).

114. "Moosehead/Whitbread: Industrial Franchise and No-Challenge Clauses Relating to Licensed Trademarks under EEC Competition Law", [1990] 5 ECLR 226 & [1990] 9 EIPR 334.

Events and Webinars

April 3-5, 2013 21st Annual Fordham Intellectual Property Law & Policy Conference
November 21, 2011 10th Annual Harvard Seminar
November 21, 2011 Current Developments in EU and US Antitrust Law
October 21, 2010 9th Annual Harvard Seminar
October 6, 2009 Competition and IPR: Reconciliation for Economic Growth
April 22, 2009 Advanced EC Competition Law London 2009
January 23, 2009 The Interface Between Competition Law and Intellectual Property Rights

Honors and Distinctions

Chambers Global - Competition/Antitrust; EU.

Chambers Europe - Competition/European Law. 

The Legal 500 Latin America - International Arbitration.

Education

  • Harvard Law School
    (LL.M., 1986)
  • King's College London
    (LL.B., 1984)
  • Université de Paris I - Panthéon-Sorbonne
    (Maîtrise en Droit, 1984)
  • Universidad de Málaga
    (Diploma de Estudios Hispánicos, 1980)

Bar Admissions

England & Wales - 1988
Brussels - 1997

Areas of Law


Regions